Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
18 angezeigte Treffer · Seite 2, keine Gesamtzahl für „Onerji“
Suchtreffer
Begriffe & Kennungen
Onerji · 4.5 · The concurrent use of levodopa/carbidopa with antihypertensive medicinal products can cause symptomatic postur
Eintrag öffnenOnerji · 4.5 · The use of selective MAO-B inhibitors (e.g. rasagiline and selegiline) with levodopa may be associated with or
Eintrag öffnenOnerji · 4.5 · There have been rare reports of adverse reactions, including hypertension and dyskinesia, resulting from the c
Eintrag öffnenOnerji · 4.6 Fertility, pregnancy and lactation · 1
Eintrag öffnenOnerji · 4.8 Undesirable effects · 1
Eintrag öffnenOnerji · 4.8 · 11 professionals are asked to report any suspected adverse reactions via the national reporting system listed
Eintrag öffnenOnerji · 4.8 · 9 System Organ Very common Common Uncommon Not known3 Class Somnolence, Taste disorder Eye disorders Vision bl
Eintrag öffnenOnerji · 4.8 · Description of selected adverse reactions
Eintrag öffnenOnerji · 4.8 · Dyskinesia Dyskinesia was reported as an adverse reaction in 11.5% of the Parkinson’s disease patients treated
Eintrag öffnenOnerji · 4.8 · In table 3 below, adverse reactions expected from Onerji are presented by System Organ Class (SOC) and frequen
Eintrag öffnenOnerji · 4.8 · Infusion site reactions The most common adverse reactions associated with Onerji were infusion site reactions
Eintrag öffnenOnerji · 4.8 · Neuropathy In clinical studies, 3% of the Parkinson’s disease patients treated with Onerji developed periphera
Eintrag öffnenOnerji · 4.8 · Reporting of suspected adverse reactions
Eintrag öffnenOnerji · 4.8 · Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows con
Eintrag öffnenOnerji · 4.8 · Summary of safety profile
Eintrag öffnenOnerji · 4.8 · Table 3 Tabulated list of adverse reactions System Organ Very common Common Uncommon Not known3 Class Infectio
Eintrag öffnenOnerji · 4.8 · Tabulated list of adverse reactions
Eintrag öffnenOnerji · 4.8 · The most frequent adverse reactions reported with Onerji were infusion site reactions including nodule (70.4%)
Eintrag öffnen